GlaxoSmithKline plc (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 172   

Articles published

GSK 47.81 +0.46 (0.97%)
price chart
Why Would GSK Want InterMune?
Moreover, there is another pharma giant looking to acquire the California-based biotech firm, GlaxoSmithKline plc (ADR) (GSK). InterMune specializes in research and development of novel drugs for pulmonary and orphan fibrotic disease. Its star product ...
GlaxoSmithKline plc (ADR) (NYSE:GSK) Interested In Acquiring InterMune Inc ...  BasicsMedia
Buyers Line Up For InterMune Inc (NASDAQ:ITMN) As Shares Jump 14%  WallStreetPR
Related articles »  
Sell-Side Bearish On GSK
GlaxoSmithKline plc (ADR) (GSK) has been facing a lot of scrutiny from investors lately. One of the reasons for the investors' pessimism regarding GSK is the fraud trial against the company's investigators in China.
Chinese Trial May Not Be Linked to GlaxoSmithKline plc (ADR) (GSK)
Companies around the world, who do business in China were keeping a close watch on the trial of the British company investigator, Peter Humphrey, and his American wife and business partner, Yu Yingzeng.
Related articles »  
Former GlaxoSmithKline plc (ADR) (NYSE:GSK) Consultants on Trial in China ...
Tomahawk, WI 08/08/2014 (Basicsmedia) - The trial of an expatriate corporate detective, Peter Humphrey, and Wife Yu Yingzeng, who worked as GlaxoSmithKline plc (ADR) (NYSE:GSK) consultants has officially begun in China according to CNBC's Eunice ...
GSK Investigators Sentenced By Chinese Court  Bidness Etc
Related articles »  
A Winning Biotech Strategy [GlaxoSmithKline plc (ADR), AbbVie Inc ...
biotech For former drug researcher Raghuram �Ram� Selvaraju, picking biotech stocks is both science and art. It's about understanding the competitive landscape and the mechanisms of drug action, and then making sure all the pieces fit together for a ...
Related articles »  
Analyst Downgrades: Boston Scientific Corporation, GlaxoSmithKline plc (ADR ...
Analysts are weighing in today on pharmaceutical firms Boston Scientific Corporation (NYSE:BSX) and GlaxoSmithKline plc (ADR) (NYSE:GSK), and big-box retailer Wal-Mart Stores, Inc. (NYSE:WMT). Here's a quick roundup of today's bearish brokerage ...
Related articles »  
GlaxoSmithKline plc (ADR) (GSK) Announces Quarterly Dividend of $0.65
GlaxoSmithKline plc logo GlaxoSmithKline plc (NYSE:GSK) declared a quarterly dividend on Thursday, July 24th, American Banking News.
Add Syria To The List: Whistleblower Alleges GSK Corruption  Bidness Etc
GlaxoSmithKline plc Stock Rating Reaffirmed by Barclays (GSK)  Ticker Report
Related articles »  
GlaxoSmithKline plc (ADR) To Go Ex-Dividend on August 6th (GSK)
GlaxoSmithKline plc logo GlaxoSmithKline plc (NYSE:GSK) declared a quarterly dividend on Thursday, July 24th, American Banking News.
GlaxoSmithKline plc Receives Buy Rating from Beaufort Securities (GSK)  Watch List News (press release)
Related articles »  
GSK And Genmab Announce Positive Interim Results For Ofatumumab
GlaxoSmithKline plc (GSK) and Genmab A/S announced yesterday, that an Independent Data Monitoring Committee's (IMDC) interim analysis has revealed that the Phase III study of ofatumumab (Arzerra) met its primary endpoint of improving progression ...
GSK Gets FDA Approval For Flonase
The global healthcare giant, GlaxoSmithKline plc (ADR) (GSK), announced yesterday that the US Food and Drug Administration (FDA) has approved its allergy relief spray - Flonase - for sale in the US.
Related articles »